Get PSM's Weekly Counterfeit Medicine News Roundup
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.
Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.
What happened to a Scottish woman who used black market Saxenda?
Preview NABP's online DSCSA tool.